Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses-Reference-Cited by-同舟云学术

Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses

Published:1999-07-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

da Silva Freire Coutinho Evandro¹,Fenton Mark²,Quraishi Seema N³

Affiliation:

1. Escola Nacional de Saude Publica-Fiocruz; Rua Leopoldo Bulhoes 1480/8 andar - Manguinhos Rio de Janeiro Brazil 21041-210

2. James Lind Initiative; Database of Uncertainties about the Effects of Treatments (DUETs); Summertown Pavilion Middle Way Oxford UK OX2 7LG

3. 103 Denmark Hill London UK SE5 8AF

Publisher

Wiley

Subject

Pharmacology (medical)

Reference47 articles.

1. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial;Ahlfors;Acta Psychiatrica Scandinavica Supplementum,1980

2. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate;*Dencker;Acta Psychiatrica Scandinavica Supplementum,1980

3. Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics;Dencker;Acta Psychiatrica Scandinavica Supplementum,1980

4. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia;Dencker;Acta Psychiatrica Scandinavica Supplementum,1980

5. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome;Dencker;Acta Psychiatrica Scandinavica Supplementum,1980

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal;Drug, Healthcare and Patient Safety;2023-09

2. Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting;Psychiatry Research;2022-11

3. APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA;Medical Herald of the South of Russia;2020-03-30

4. Zuclopenthixol dihydrochloride for schizophrenia;Cochrane Database of Systematic Reviews;2017-11-16

5. Zuclopenthixol versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2015-12-01